Utah Medical Products, Inc. (UTMD)
NASDAQ: UTMD · Real-Time Price · USD
72.12
+0.12 (0.17%)
Aug 19, 2026, 4:00 PM EDT - Market closed
Utah Medical Products Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 36.11 | 38.52 | 40.9 | 50.22 | 52.28 | 49.05 | |
Revenue Growth | -7.00% | -5.83% | -18.56% | -3.94% | 6.58% | 16.30% |
Cost of Revenue | 15.2 | 16.52 | 16.76 | 20.19 | 20.09 | 18.14 |
Gross Profit | 20.91 | 22 | 24.14 | 30.04 | 32.2 | 30.92 |
Selling, General & Admin | 8.25 | 8.58 | 7.6 | 12.7 | 11.91 | 11.51 |
Research & Development | 0.69 | 0.67 | 0.81 | 0.56 | 0.49 | 0.53 |
Operating Expenses | 8.94 | 9.24 | 8.41 | 13.26 | 12.41 | 12.04 |
Operating Income | 11.97 | 12.76 | 15.73 | 16.78 | 19.79 | 18.88 |
Interest & Investment Income | 2.81 | 2.81 | 3.37 | 3.04 | 0.66 | 0.17 |
Currency Exchange Gain (Loss) | -0.03 | -0.02 | 0 | - | - | - |
Other Non Operating Income (Expenses) | -0.17 | -0.08 | -0.16 | 0.28 | 0.21 | 0.02 |
EBT Excluding Unusual Items | 14.59 | 15.47 | 18.94 | 20.09 | 20.66 | 19.06 |
Legal Settlements | -1.7 | -1.36 | -2.14 | - | - | - |
Pretax Income | 12.89 | 14.11 | 16.8 | 20.09 | 20.66 | 19.06 |
Income Tax Expense | 2.4 | 2.82 | 2.93 | 3.45 | 4.19 | 4.27 |
Net Income | 10.49 | 11.29 | 13.87 | 16.64 | 16.47 | 14.79 |
Net Income to Common | 10.49 | 11.29 | 13.87 | 16.64 | 16.47 | 14.79 |
Net Income Growth | -16.46% | -18.65% | -16.60% | 0.98% | 11.39% | 36.95% |
Shares Outstanding (Basic) | 3 | 3 | 4 | 4 | 4 | 4 |
Shares Outstanding (Diluted) | 3 | 3 | 4 | 4 | 4 | 4 |
Shares Change | -4.75% | -7.51% | -3.68% | -0.17% | -0.46% | -0.33% |
EPS (Basic) | 3.28 | 3.48 | 3.96 | 4.58 | 4.53 | 4.05 |
EPS (Diluted) | 3.28 | 3.48 | 3.96 | 4.57 | 4.52 | 4.04 |
EPS Growth | -12.36% | -12.06% | -13.33% | 1.11% | 11.88% | 37.41% |
Free Cash Flow | 11.45 | 14.32 | 14.6 | 21.64 | 20.34 | 20.65 |
Free Cash Flow Per Share | 3.58 | 4.42 | 4.17 | 5.95 | 5.58 | 5.64 |
Dividend Per Share | 1.235 | 1.225 | 1.205 | 1.185 | 1.165 | 0.855 |
Dividend Growth | 1.65% | 1.66% | 1.69% | 1.72% | 36.26% | -23.66% |
Gross Margin | 57.90% | 57.12% | 59.03% | 59.81% | 61.58% | 63.03% |
Operating Margin | 33.15% | 33.12% | 38.46% | 33.40% | 37.85% | 38.49% |
Profit Margin | 29.04% | 29.30% | 33.92% | 33.12% | 31.51% | 30.15% |
Free Cash Flow Margin | 31.70% | 37.18% | 35.70% | 43.09% | 38.90% | 42.10% |
EBITDA | 14.37 | 15.71 | 18.53 | 23.09 | 26.82 | 26.16 |
EBITDA Margin | 39.79% | 40.78% | 45.30% | 45.98% | 51.30% | 53.33% |
D&A For EBITDA | 2.4 | 2.95 | 2.8 | 6.32 | 7.03 | 7.28 |
EBIT | 11.97 | 12.76 | 15.73 | 16.78 | 19.79 | 18.88 |
EBIT Margin | 33.15% | 33.12% | 38.46% | 33.40% | 37.85% | 38.49% |
Effective Tax Rate | 18.61% | 20.01% | 17.43% | 17.19% | 20.26% | 22.42% |